Lower limb peripheral arterial disease
Everything NICE has said on diagnosing and managing lower limb peripheral arterial disease in an interactive flowchart
Search results
361 results
-
-
Thousands of lung cancer patients to benefit from life-extending treatment
A potentially life-extending treatment for some people with non-squamous, non-small-cell lung cancer (NSCLC) will now be available on the NHS following its approval by NICE in draft guidance published today.
-
NICE's processes of technology evaluation - presenting a case for change
NICE has today (4 February 2021) launched a public consultation on proposals for changes to the processes it uses to develop its guidance on medicines, medical devices, diagnostics and digital health technologies.
-
Physical activity
Everything NICE has said on interventions, programmes and strategies to encourage people of all ages to be physically active in an interactive flowchart
-
Obesity
Everything NICE has said on preventing, identifying, assessing and managing obesity in an interactive flowchart
-
Age-related macular degeneration
Everything NICE has said on age-related macular degeneration in an interactive flowchart
-
Brain tumours and metastases
Everything NICE has said on brain tumours in adults, including cancer, in an interactive flowchart
-
Suspected cancer recognition and referral
Everything NICE has said on suspected cancer, recognition and selection for referral or investigation in primary care in an interactive flowchart
-
Cervical cancer
Everything NICE has said on screening and managing cervical cancer in an interactive flowchart
-
Abortion care
Everything NICE has said on abortion care in an interactive flowchart.
-
Dyspepsia and gastro-oesophageal reflux disease
Everything NICE has said on investigating and managing dyspepsia and gastro-oesophageal reflux disease in an interactive flowchart
-
In women with type 1 diabetes who are already pregnant, what is the most effective method of glucose monitoring to improve maternal and baby outcomes: continuous glucose monitoring flash glucose monitoring?
Recommendation ID NG3/7 Question In women with type 1 diabetes who are already pregnant, what is the most effective method of glucose monitoring
-
In women with type 1 diabetes who are planning to become pregnant, what is the most effective method of glucose monitoring to improve maternal and baby outcomes: continuous glucose monitoring flash glucose monitoring intermittent capillary blood glucose monitoring?
Recommendation ID NG3/6 Question In women with type 1 diabetes who are planning to become pregnant, what is the most effective method of
-
What is the most clinically and cost-effective tool for diagnosing peripheral arterial disease in people with diabetes?
Recommendation ID CG147/6 Question What is the most clinically and cost-effective tool for diagnosing peripheral arterial disease in people
-
What is the most clinically and cost-effective tool for establishing the severity of peripheral arterial disease and the impact on mortality, morbidity and limb amputation in people with diabetes?
Recommendation ID CG147/7 Question What is the most clinically and cost-effective tool for establishing the severity of peripheral arterial
-
In children and young people with diabetic ketoacidosis, what is the most effective resuscitation fluid (0.9% sodium chloride vs PlasmaLyte 148) for managing DKA?
Recommendation ID NG18/6 Question In children and young people with diabetic ketoacidosis, what is the most effective resuscitation fluid
-
What are the most clinically effective interventions (including social prescribing and structured community support) for managing post‑COVID‑19 syndrome? Does effectiveness vary for different population groups (for example sex, age, socioeconomic group, black, Asian and minority ethnic group communities or people with learning disabilities)? Do any symptoms of post‑COVID‑19 syndrome predict the need for specialist intervention? Are there clusters of symptoms that identify response to interventions in post‑COVID‑19 syndrome? What is the clinical effectiveness of different service models of multimodality/multidisciplinary post‑COVID‑19 syndrome rehabilitation in improving patient‑reported outcomes (such as quality of life)? What is the clinical effectiveness of exercise interventions for people with post‑COVID‑19 syndrome? Does effectiveness vary for different population groups (for example sex, age, socioeconomic group, black, Asian and minority ethnic group communities or people with learning disabilities)? Does early exercise rehabilitation assist in improving symptoms of post‑COVID‑19 syndrome?
Recommendation ID NG188/2 Question What are the most clinically effective interventions (including social prescribing and structured community
-
What is the most clinically and cost-effective dual antiplatelet therapy for people aged 75 and over with an acute coronary syndrome, who are having percutaneous coronary intervention (PCI)?
Recommendation ID NG185/1 Question What is the most clinically and cost-effective dual antiplatelet therapy for people aged 75 and over
-
Evidence on the safety and efficacy of balloon cryoablation for squamous dysplasia of the oesophagus is inadequate in quantity and quality. Therefore, this procedure should only be used in the context of research. This could be in the form of randomised controlled trials or published registry data. Find out what only in research means on the NICE interventional procedures guidance page .
Recommendation ID IPG683/1 Question Evidence on the safety and efficacy of balloon cryoablation for squamous dysplasia of the oesophagus
-
Evidence on the safety and efficacy of balloon cryoablation for Barrett's oesophagus is inadequate in quantity and quality. Therefore, this procedure should only be used in the context of research. This could be in the form of randomised controlled trials or published registry data. Find out what only in research means on the NICE interventional procedures guidance page .
Recommendation ID IPG682/1 Question Evidence on the safety and efficacy of balloon cryoablation for Barrett's oesophagus is inadequate
-
What is the clinical and cost effectiveness of opioids for the management of acute sciatica?
Recommendation ID NG59/8 Question What is the clinical and cost effectiveness of opioids for the management of acute sciatica?
-
Evidence on the safety of the swallowable gastric balloon capsule for weight loss shows infrequent but potentially serious adverse events: For people who need to lose weight in the short term for medical reasons, the evidence of efficacy is adequate to support the use of this procedure provided that special arrangements are in place for clinical governance, consent and audit. Find out what special arrangements mean on the NICE interventional procedures guidance page . For people who are aiming for long-term weight loss, the evidence on efficacy is inadequate in quantity and quality, so the procedure should only be used in the context of research. Find out what only in research means on the NICE interventional procedures guidance page .
Recommendation ID IPG684/1 Question Evidence on the safety of the swallowable gastric balloon capsule for weight loss shows infrequent
-
What symptoms do children, young people, pregnant women and older people with suspected post‑COVID‑19 syndrome present with?
Recommendation ID NG188/5 Question What symptoms do children, young people, pregnant women and older people with suspected post‑COVID‑19
-
Evidence on the safety of pressurised intraperitoneal aerosol chemotherapy for peritoneal carcinomatosis shows that this procedure can cause serious but well-recognised side effects. Evidence on its efficacy is inadequate in quality. Therefore, this procedure should only be used in the context of research. Find out what only in research means on the NICE website .
Recommendation ID IPG681/1 Question Evidence on the safety of pressurised intraperitoneal aerosol chemotherapy for peritoneal carcinomatosis
-
What is the prevalence and incidence of post-COVID-19 syndrome? Does it differ from the prevalence and incidence across different population groups (for example in black, Asian and minority ethnic group communities)?
Recommendation ID NG188/3 Question What is the prevalence and incidence of post-COVID-19 syndrome? Does it differ from the prevalence and
-
Develop and validate new and existing screening tools (including physical, psychological and psychiatric aspects) for post-COVID-19 syndrome in a UK population. What tools are validated for screening for post‑COVID‑19 syndrome, which are the most accurate at identifying post‑COVID‑19 syndrome in a UK population and what is their effectiveness in guiding management?
Recommendation ID NG188/7 Question Develop and validate new and existing screening tools (including physical, psychological and
-
What is the clinical effectiveness of D-dimer and other blood tests and clinical features as prognostic markers of developing post‑COVID‑19 syndrome?
Recommendation ID NG188/4 Question What is the clinical effectiveness of D-dimer and other blood tests and clinical features as prognostic
-
What factors, including identifiable clusters of symptoms, influence: the risk of developing post-COVID-19 syndrome the trajectory of post-COVID-19 syndrome?
Recommendation ID NG188/1 Question What factors, including identifiable clusters of symptoms, influence: the risk of developing
-
What is the natural history of post-COVID-19 syndrome?
Recommendation ID NG188/6 Question What is the natural history of post-COVID-19 syndrome? Any explanatory notes(if applicable)
-
Speaking with one language: How using a common data model might speed up decision making
NICE is taking part in the European Health Data and Evidence Network (EHDEN) project, which is exploring the use of common data models for healthcare research. This could support faster patient access to innovative medicines in areas of unmet need.
-
NICE is gearing up for the evaluation of further digital health technologies as pilot project produces first result
Following the successful evaluation of Zio XT, developers of digital health technologies are encouraged to engage with NICE through one of several different routes
-
Treatment for men with enlarged prostate is recommended by NICE for NHS adoption
Final guidance from NICE recommends the PLASMA system
-
NICE collaboration on streamlined licensing and patient access process for new medicines opened on January 1st
Companies can now submit medicines for the new Innovative Licensing and Access Pathway (ILAP) following close collaboration between the NICE, drug regulators, the NHS and equivalent organisations in Scotland.
-
Early and locally advanced breast cancer
Everything NICE has said on diagnosing and treating early and locally advanced breast cancer in an interactive flowchart
-
Shared decision making is an integral part of healthcare, says NICE
Shared decision making between patients and clinicians should be embedded throughout healthcare services, says NICE, in draft guidance published today.
-
NICE, RCGP and SIGN publish guideline on managing the long-term effects of COVID-19
NICE, the Royal College of General Practitioners (RCGP) and the Scottish Intercollegiate Guidelines Network (SIGN) have today (18 December 2020) published a guideline on the management of the long-term effects of COVID-19 (also known as Long COVID).
-
Vitamin D: supplement use in specific population groups
Everything NICE has said on preventing vitamin D deficiency in specific population groups in an interactive flowchart
-
NICE, PHE and SACN publish rapid COVID-19 guidance on vitamin D
NICE, PHE and SACN have today published rapid guidance on vitamin D for COVID-19.
-
Type 2 diabetes in adults
Everything NICE has said on managing type 2 diabetes in adults in an interactive flowchart
-
Acutely ill patients in hospital
Everything NICE has said on recognising and responding to acute illness in adults in hospital in an interactive flowchart
-
Urinary incontinence in neurological disease
Everything NICE has said on managing lower urinary tract dysfunction resulting from neurological disease and injury in an interactive flowchart
-
Diabetes in children and young people
Everything NICE has said on diagnosing and managing type 1 and 2 diabetes in children and young people in an interactive flowchart
-
Type 1 diabetes in adults
Everything NICE has said on diagnosing and managing type 1 diabetes in adults in an interactive flowchart
-
Blood and immune system conditions
Everything NICE has said on blood and immune system conditions in an interactive flowchart
-
Pancreatitis
Everything NICE has said on pancreatitis in an interactive flowchart
-
Eating disorders
Everything NICE has said on identifying and managing eating disorders in people 8 years and over in an interactive flowchart
-
New LSE master's degree in Evaluation of Health Care Interventions and Outcomes
NICE is collaborating with the London School of Economics and Political Science (LSE) to develop an executive master’s degree in health care decision-making.
-
NICE and NIHR: working together to produce research with impact
Alice and Zoe discuss how the National Institute of Health Research (NIHR) and NICE work in partnership and identify key research priorities from NICE guidance.
-
Preventing type 2 diabetes
Everything NICE has said on preventing type 2 diabetes in an interactive flowchart
-
Parkinson's disease
Everything NICE has said on diagnosing and managing Parkinson's disease in adults in primary and secondary care in an interactive flowchart